1. Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial 
Marianna Christodoulou, MRCP, MRes, Fiona Blackhall, MD, PhD, Hitesh Mistry, PhD, Ahmet Leylek, PhD, Joost Knegjens, MD, Vincent Remouchamps, MD, PhD, Isabelle Martel-Lafay, MD, Núria Farré, MD, Matjaž Zwitter, MD, PhD, Delphine Lerouge, MD, Nicolas Pourel, MD, Henri Janicot, MD, Arnaud Scherpereel, MD, PhD, Caroline Tissing-Tan, MD, Karin Peignaux, MD, Xavier Geets, MD, PhD, Krzysztof Konopa, MD, PhD, Corinne Faivre-Finn, MD, PhD 
Journal of Thoracic Oncology 
Volume 14, Issue 1, Pages (January 2019)
DOI: /j.jtho
Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1 Patient allocation to age groups.
Journal of Thoracic Oncology  , 63-71DOI: ( /j.jtho )
Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Kaplan-Meier curves for (A) overall survival and (B) progression-free survival for elderly (dashed red line) and younger (blue line) groups. Hazard ratios (HRs), 95% confidence intervals (Cis), p values, and number of patients at risk against yearly intervals are shown.
Journal of Thoracic Oncology  , 63-71DOI: ( /j.jtho )
Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions

4. Figure 3
Kaplan-Meier curves for overall survival for elderly patients who received twice-daily (BD) (dashed red line) or once-daily (OD) radiotherapy (blue line). Hazard ratios (HRs), 95% confidence intervals (Cis), p values and number of patients at risk against yearly intervals are shown.
Journal of Thoracic Oncology  , 63-71DOI: ( /j.jtho )
Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions